| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |